Plus   Neg

Fluor Corp. Issues Earnings Guidance

Fluor Corporation (FLR) said, for 2021, the company is establishing its initial adjusted EPS guidance at a range of $0.50 to $0.80. The company said its guidance excludes NuScale related expenses and any impact from foreign currency exchange gains or losses, restructuring or impairments.

Fourth quarter net loss from continuing operations was $0.82 per share, compared to a loss of $2.10 per share, a year ago. Revenue for the fourth quarter was $3.7 billion compared to $4.4 billion a year ago.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies. Beverages giant Coca-Cola reported a 19 percent decline in profit for the second quarter from last year as a revenue growth of 5 percent and improved margins were offset by higher income taxes and interest expense. However, adjusted earnings per share and revenues topped analysts' expectations. The company also maintained its adjusted earnings and organic revenue growth outlook for fiscal 2021.
Follow RTT